Pharma CEO Hid FDA Hold From Investors, Jury Finds
The CEO of Immunosyn Corp., a drugmaker whose sole product was derived from goat's blood, was responsible for upselling investors on the drug's promise by not warning them that the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article